ArticleBMC cancer2021

ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition.

Mark G Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.